BioMarin's ROCTAVIAN Wins Food and Drug Administration Approval As First Gene Therapy for Severe Hemophilia A

Human Gene Therapy,Volume 34, Issue 15-16, Page 665-668, August 2023.

Source: Human Gene Therapy - August 16, 2023 Category: Genetics & Stem Cells Authors: Alex Philippidis Source Type: research